Our Expertise, Your Discovery
Cellomatics Biosciences is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology, Immuno-oncology, Immunology, Inflammation and Respiratory therapeutic areas.
Based in the UK at Colwick Quays Business Park, Nottingham, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies.
Our scientific personnel have expertise in diverse technologies and therapeutic areas. We offer complex cell-based models in the form of monocultures, co-cultures or 3D cultures to replicate in vivo physiology as closely as possible.
With years of experience, our team members have the skills needed to understand your requirements and deliver bespoke, innovative and practical solutions.
Our Therapeutic Expertise
Cellomatics Biosciences has a team of qualified scientists with several years of in vitro bioassay experience. Our strengths lie in our scientific team members, who are experts in bioassay development and validation. Over the years, we have developed, optimised and validated several clinically relevant in vitro disease models within the therapeutic areas described below.
How we can help
We offer expert bioassay services tailored to suit your project objectives. During this process, we will provide updates on the progress and be available to discuss findings. The service is modular; if you desire a specific standalone service, please get in touch.
Latest Insights
Check out the latest news, blogs and podcasts from Cellomatics.
FAQ
Contract bioassay services provide high-quality experimental data that supports key decision-making in drug discovery and enable efficient evaluation of compound activity in biologically relevant systems. Working with a CRO such as Cellomatics adds further value through access to specialised expertise, advanced assay platforms, and flexible, bespoke study design, helping accelerate timelines while ensuring robust and reproducible data.
They are particularly valuable when internal resources are limited, timelines are tight, or specialised expertise is required. Cellomatics supports rapid project initiation with ready-to-deploy assay platforms.
Established workflows and experienced scientific teams reduce setup time and accelerate data generation, keeping projects on schedule.
Reliability is achieved through validated methods, controlled workflows, and rigorous quality control processes. Cellomatics maintains strict reproducibility standards across all studies.
Advanced assays are supported by specialised instrumentation and expert teams. Cellomatics delivers complex multi-parametric studies across immunology, oncology, and inflammation.
Yes. Study design can be adapted to meet specific project needs, including model selection, assay format, and readout. This flexibility ensures biologically relevant outcomes.